Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1749

1.

Ibrutinib associated invasive fungal diseases in patients with CLL and non-Hodgkin lymphoma: an observational study.

Ruchlemer R, Ben-Ami R, Bar-Meir M, Brown JR, Malphettes M, Mous R, Tonino SH, Soussain C, Barzic N, Messina JA, Jain P, Cohen R, Hill B, Mulligan SP, Nijland M, Herishanu Y, Benjamini O, Tadmor T, Okamoto K, Arthurs B, Gottesman B, Kater AP, Talha M, Eichhorst B, Korem M, Bogot N, De Boer F, Rowe JM, Lachish T.

Mycoses. 2019 Sep 13. doi: 10.1111/myc.13001. [Epub ahead of print]

PMID:
31520441
2.

11 C-PK11195 PET imaging and white matter changes in Parkinson's disease dementia.

Nicastro N, Surendranathan A, Mak E, Rowe JB, O'Brien JT.

Ann Clin Transl Neurol. 2019 Sep 10. doi: 10.1002/acn3.50877. [Epub ahead of print]

3.

Potential tools for eradicating HIV reservoirs in the brain: the development of Trojan horse prodrugs for the inhibition of P-glycoprotein with anti-HIV-1 activity.

Agrawal N, Rowe J, Lan J, Yu Q, Hrycyna CA, Chmielewski J.

J Med Chem. 2019 Sep 11. doi: 10.1021/acs.jmedchem.9b00779. [Epub ahead of print]

PMID:
31505928
4.
5.

Rosetting revisited: a critical look at the evidence for host erythrocyte receptors in Plasmodium falciparum rosetting.

McQuaid F, Rowe JA.

Parasitology. 2019 Aug 28:1-43. doi: 10.1017/S0031182019001288. [Epub ahead of print] No abstract available.

PMID:
31455446
6.

Hematopoietic Cell Transplantation in the Treatment of Adult Acute Lymphoblastic Leukemia: Updated 2019 Evidence-Based Review from the American Society for Transplantation and Cellular Therapy.

DeFilipp Z, Advani AS, Bachanova V, Cassaday RD, Deangelo DJ, Kebriaei P, Rowe JM, Seftel MD, Stock W, Tallman MS, Fanning S, Inamoto Y, Kansagra A, Johnston L, Nagler A, Sauter CS, Savani BN, Perales MA, Carpenter PA, Larson RA, Weisdorf D.

Biol Blood Marrow Transplant. 2019 Aug 22. pii: S1083-8791(19)30528-2. doi: 10.1016/j.bbmt.2019.08.014. [Epub ahead of print] Review.

PMID:
31446198
7.

Biomagnetic biomarkers for dementia: A pilot multicentre study with a recommended methodological framework for magnetoencephalography.

Hughes LE, Henson RN, Pereda E, Bruña R, López-Sanz D, Quinn AJ, Woolrich MW, Nobre AC, Rowe JB, Maestú F; BioFIND Working Group.

Alzheimers Dement (Amst). 2019 Jun 14;11:450-462. doi: 10.1016/j.dadm.2019.04.009. eCollection 2019 Dec.

8.

Serologic responses to the PfEMP1 DBL-CIDR head structure may be a better indicator of malaria exposure than those to the DBL-α tag.

Stucke EM, Niangaly A, Berry AA, Bailey JA, Coulibaly D, Ouattara A, Lyke KE, Laurens MB, Dara A, Adams M, Pablo J, Jasinskas A, Nakajima R, Zhou AE, Agrawal S, Friedman-Klabanoff DJ, Takala-Harrison S, Kouriba B, Kone AK, Rowe JA, Doumbo OK, Felgner PL, Thera MA, Plowe CV, Travassos MA.

Malar J. 2019 Aug 13;18(1):273. doi: 10.1186/s12936-019-2905-9.

9.

European Ultrahigh-Field Imaging Network for Neurodegenerative Diseases (EUFIND).

Düzel E, Acosta-Cabronero J, Berron D, Biessels GJ, Björkman-Burtscher I, Bottlaender M, Bowtell R, Buchem MV, Cardenas-Blanco A, Boumezbeur F, Chan D, Clare S, Costagli M, de Rochefort L, Fillmer A, Gowland P, Hansson O, Hendrikse J, Kraff O, Ladd ME, Ronen I, Petersen E, Rowe JB, Siebner H, Stoecker T, Straub S, Tosetti M, Uludag K, Vignaud A, Zwanenburg J, Speck O.

Alzheimers Dement (Amst). 2019 Jul 31;11:538-549. doi: 10.1016/j.dadm.2019.04.010. eCollection 2019 Dec.

10.

Mammary mesenchymal and fibroepithelial lesions: An illustrated cytomorphologic update with differential diagnoses.

Khattab RA, Rowe JJ, Booth CN, Sneige N, Fong N, Pantanowitz L, Oshilaja O, Brainard JA, Downs-Kelly EP, Dawson A, Sturgis CD.

Diagn Cytopathol. 2019 Oct;47(10):1100-1118. doi: 10.1002/dc.24288. Epub 2019 Jul 25. Review.

PMID:
31343114
11.

Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases.

Betts MJ, Kirilina E, Otaduy MCG, Ivanov D, Acosta-Cabronero J, Callaghan MF, Lambert C, Cardenas-Blanco A, Pine K, Passamonti L, Loane C, Keuken MC, Trujillo P, Lüsebrink F, Mattern H, Liu KY, Priovoulos N, Fliessbach K, Dahl MJ, Maaß A, Madelung CF, Meder D, Ehrenberg AJ, Speck O, Weiskopf N, Dolan R, Inglis B, Tosun D, Morawski M, Zucca FA, Siebner HR, Mather M, Uludag K, Heinsen H, Poser BA, Howard R, Zecca L, Rowe JB, Grinberg LT, Jacobs HIL, Düzel E, Hämmerer D.

Brain. 2019 Sep 1;142(9):2558-2571. doi: 10.1093/brain/awz193.

PMID:
31327002
12.

Language impairment in progressive supranuclear palsy and corticobasal syndrome.

Peterson KA, Patterson K, Rowe JB.

J Neurol. 2019 Jul 18. doi: 10.1007/s00415-019-09463-1. [Epub ahead of print] Review.

PMID:
31321513
13.

Neuroinflammation and Functional Connectivity in Alzheimer's Disease: Interactive Influences on Cognitive Performance.

Passamonti L, Tsvetanov KA, Jones PS, Bevan-Jones WR, Arnold R, Borchert RJ, Mak E, Su L, O'Brien JT, Rowe JB.

J Neurosci. 2019 Sep 4;39(36):7218-7226. doi: 10.1523/JNEUROSCI.2574-18.2019. Epub 2019 Jul 18.

14.

Neural Correlates of Passive Position Finger Sense After Stroke.

Ingemanson ML, Rowe JR, Chan V, Riley J, Wolbrecht ET, Reinkensmeyer DJ, Cramer SC.

Neurorehabil Neural Repair. 2019 Sep;33(9):740-750. doi: 10.1177/1545968319862556. Epub 2019 Jul 18.

15.

Tackling gaps in developing life-changing treatments for dementia.

Mauricio R, Benn C, Davis J, Dawson G, Dawson LA, Evans A, Fox N, Gallacher J, Hutton M, Isaac J, Jones DNC, Jones L, Lalli G, Libri V, Lovestone S, Moody C, Noble W, Perry H, Pickett J, Reynolds D, Ritchie C, Rohrer JD, Routledge C, Rowe J, Snyder H, Spires-Jones T, Swartz J, Truyen L, Whiting P; Therapeutics for Dementia Consortium.

Alzheimers Dement (N Y). 2019 Jun 24;5:241-253. doi: 10.1016/j.trci.2019.05.001. eCollection 2019. Review.

16.

Connectomics and molecular imaging in neurodegeneration.

Bischof GN, Ewers M, Franzmeier N, Grothe MJ, Hoenig M, Kocagoncu E, Neitzel J, Rowe JB, Strafella A, Drzezga A, van Eimeren T; MINC faculty.

Eur J Nucl Med Mol Imaging. 2019 Jul 11. doi: 10.1007/s00259-019-04394-5. [Epub ahead of print]

PMID:
31292699
17.

Test Your Memory (TYM test): diagnostic evaluation of patients with non-Alzheimer dementias.

Brown J, Wiggins J, Lansdall CJ, Dawson K, Rittman T, Rowe JB.

J Neurol. 2019 Jul 2. doi: 10.1007/s00415-019-09447-1. [Epub ahead of print]

PMID:
31267204
18.

In Vivo Assay of Cortical Microcircuitry in Frontotemporal Dementia: A Platform for Experimental Medicine Studies.

Shaw AD, Hughes LE, Moran R, Coyle-Gilchrist I, Rittman T, Rowe JB.

Cereb Cortex. 2019 Jun 19. pii: bhz024. doi: 10.1093/cercor/bhz024. [Epub ahead of print]

PMID:
31216360
19.

A Phase II, Multicenter, Single-Arm Study of Mipsagargin (G-202) as a Second-Line Therapy Following Sorafenib for Adult Patients with Progressive Advanced Hepatocellular Carcinoma.

Mahalingam D, Peguero J, Cen P, Arora SP, Sarantopoulos J, Rowe J, Allgood V, Tubb B, Campos L.

Cancers (Basel). 2019 Jun 17;11(6). pii: E833. doi: 10.3390/cancers11060833.

20.

Management factors associated with bovine respiratory disease in preweaned calves on California dairies: The BRD 100 study.

Maier GU, Love WJ, Karle BM, Dubrovsky SA, Williams DR, Champagne JD, Anderson RJ, Rowe JD, Lehenbauer TW, Van Eenennaam AL, Aly SS.

J Dairy Sci. 2019 Aug;102(8):7288-7305. doi: 10.3168/jds.2018-14773. Epub 2019 Jun 13.

PMID:
31202656
21.

Development of a clinical scoring system for bovine respiratory disease in weaned dairy calves.

Maier GU, Rowe JD, Lehenbauer TW, Karle BM, Williams DR, Champagne JD, Aly SS.

J Dairy Sci. 2019 Aug;102(8):7329-7344. doi: 10.3168/jds.2018-15474. Epub 2019 Jun 13.

PMID:
31202651
22.

Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission.

Rashidi A, Hamadani M, Zhang MJ, Wang HL, Abdel-Azim H, Aljurf M, Assal A, Bajel A, Bashey A, Battiwalla M, Beitinjaneh AM, Bejanyan N, Bhatt VR, Bolaños-Meade J, Byrne M, Cahn JY, Cairo M, Ciurea S, Copelan E, Cutler C, Daly A, Diaz MA, Farhadfar N, Gale RP, Ganguly S, Grunwald MR, Hahn T, Hashmi S, Hildebrandt GC, Holland HK, Hossain N, Kanakry CG, Kharfan-Dabaja MA, Khera N, Koc Y, Lazarus HM, Lee JW, Maertens J, Martino R, McGuirk J, Munker R, Murthy HS, Nakamura R, Nathan S, Nishihori T, Palmisiano N, Patel S, Pidala J, Olin R, Olsson RF, Oran B, Ringden O, Rizzieri D, Rowe J, Savoie ML, Schultz KR, Seo S, Shaffer BC, Singh A, Solh M, Stockerl-Goldstein K, Verdonck LF, Wagner J, Waller EK, De Lima M, Sandmaier BM, Litzow M, Weisdorf D, Romee R, Saber W.

Blood Adv. 2019 Jun 25;3(12):1826-1836. doi: 10.1182/bloodadvances.2019000050.

23.

Meta-analytic Evidence for the Plurality of Mechanisms in Transdiagnostic Structural MRI Studies of Hallucination Status.

Rollins CPE, Garrison JR, Simons JS, Rowe JB, O'Callaghan C, Murray GK, Suckling J.

EClinicalMedicine. 2019 Feb 21;8:57-71. doi: 10.1016/j.eclinm.2019.01.012. eCollection 2019 Feb.

24.

Education modulates brain maintenance in presymptomatic frontotemporal dementia.

Gazzina S, Grassi M, Premi E, Cosseddu M, Alberici A, Archetti S, Gasparotti R, Van Swieten J, Galimberti D, Sanchez-Valle R, Laforce RJ, Moreno F, Synofzik M, Graff C, Masellis M, Tartaglia MC, Rowe JB, Vandenberghe R, Finger E, Tagliavini F, de Mendonça A, Santana I, Butler CR, Ducharme S, Gerhard A, Danek A, Levin J, Otto M, Frisoni G, Sorbi S, Padovani A, Rohrer JD, Borroni B; Genetic FTD Initiative, GENFI.

J Neurol Neurosurg Psychiatry. 2019 Oct;90(10):1124-1130. doi: 10.1136/jnnp-2019-320439. Epub 2019 Jun 10.

PMID:
31182509
25.

Inflammation and cerebral small vessel disease: A systematic review.

Low A, Mak E, Rowe JB, Markus HS, O'Brien JT.

Ageing Res Rev. 2019 Aug;53:100916. doi: 10.1016/j.arr.2019.100916. Epub 2019 Jun 10. Review.

PMID:
31181331
26.

Efficacy outcomes in the treatment of older or medically unfit patients with acute myeloid leukaemia: A systematic review and meta-analysis.

Stone A, Zukerman T, Flaishon L, Yakar RB, Rowe JM.

Leuk Res. 2019 Jul;82:36-42. doi: 10.1016/j.leukres.2019.05.007. Epub 2019 May 21.

PMID:
31152922
27.

Cysteine and hydrophobic residues in CDR3 serve as distinct T-cell self-reactivity indices.

Daley SR, Koay HF, Dobbs K, Bosticardo M, Wirasinha RC, Pala F, Castagnoli R, Rowe JH, Ott de Bruin LM, Keles S, Lee YN, Somech R, Holland SM, Delmonte OM, Draper D, Maxwell S, Niemela J, Stoddard J, Rosenzweig SD, Poliani PL, Capo V, Villa A, Godfrey DI, Notarangelo LD.

J Allergy Clin Immunol. 2019 Jul;144(1):333-336. doi: 10.1016/j.jaci.2019.03.022. Epub 2019 Apr 30. No abstract available.

PMID:
31053347
28.

Precision Medicine in Internal Medicine.

Kiryluk K, Goldstein DB, Rowe JW, Gharavi AG, Wapner R, Chung WK.

Ann Intern Med. 2019 May 7;170(9):635-642. doi: 10.7326/M18-0425. Epub 2019 Apr 30.

PMID:
31035290
29.

The neuroanatomical and neurochemical basis of apathy and impulsivity in frontotemporal lobar degeneration.

Passamonti L, Lansdall CJ, Rowe JB.

Curr Opin Behav Sci. 2018 Aug;22:14-20. doi: 10.1016/j.cobeha.2017.12.015.

30.

Challenges For Middle-Income Elders In An Aging Society.

Rowe JW.

Health Aff (Millwood). 2019 May;38(5):101377hlthaff201900095. doi: 10.1377/hlthaff.2019.00095. Epub 2019 Apr 24.

PMID:
31017482
31.

Neuroimaging biomarkers for clinical trials in atypical parkinsonian disorders: Proposal for a Neuroimaging Biomarker Utility System.

van Eimeren T, Antonini A, Berg D, Bohnen N, Ceravolo R, Drzezga A, Höglinger GU, Higuchi M, Lehericy S, Lewis S, Monchi O, Nestor P, Ondrus M, Pavese N, Peralta MC, Piccini P, Pineda-Pardo JÁ, Rektorová I, Rodríguez-Oroz M, Rominger A, Seppi K, Stoessl AJ, Tessitore A, Thobois S, Kaasinen V, Wenning G, Siebner HR, Strafella AP, Rowe JB.

Alzheimers Dement (Amst). 2019 Apr 2;11:301-309. doi: 10.1016/j.dadm.2019.01.011. eCollection 2019 Dec.

32.

ApoE4 lowers age at onset in patients with frontotemporal dementia and tauopathy independent of amyloid-β copathology.

Koriath C, Lashley T, Taylor W, Druyeh R, Dimitriadis A, Denning N, Williams J, Warren JD, Fox NC, Schott JM, Rowe JB, Collinge J, Rohrer JD, Mead S.

Alzheimers Dement (Amst). 2019 Mar 19;11:277-280. doi: 10.1016/j.dadm.2019.01.010. eCollection 2019 Dec.

33.

Superior outcome of patients with favorable-risk acute myeloid leukemia using consolidation with autologous stem cell transplantation.

Beyar-Katz O, Lavi N, Ringelstein-Harlev S, Henig I, Yehudai-Ofir D, Haddad N, Fineman R, Ofran Y, Nov Y, Sahar D, Moustafa-Hawash N, Rowe JM, Zuckerman T.

Leuk Lymphoma. 2019 Apr 3:1-8. doi: 10.1080/10428194.2019.1594214. [Epub ahead of print]

PMID:
30943060
34.

Deep and Frequent Phenotyping study protocol: an observational study in prodromal Alzheimer's disease.

Koychev I, Lawson J, Chessell T, Mackay C, Gunn R, Sahakian B, Rowe JB, Thomas AJ, Rochester L, Chan D, Tom B, Malhotra P, Ballard C, Chessell I, Ritchie CW, Raymont V, Leroi I, Lengyel I, Murray M, Thomas DL, Gallacher J, Lovestone S.

BMJ Open. 2019 Mar 23;9(3):e024498. doi: 10.1136/bmjopen-2018-024498.

35.

Antibodies to Peptides in Semiconserved Domains of RIFINs and STEVORs Correlate with Malaria Exposure.

Zhou AE, Berry AA, Bailey JA, Pike A, Dara A, Agrawal S, Stucke EM, Ouattara A, Coulibaly D, Lyke KE, Laurens MB, Adams M, Takala-Harrison S, Pablo J, Jasinskas A, Nakajima R, Niangaly A, Kouriba B, Kone AK, Rowe JA, Doumbo OK, Thera MA, Patel JJ, Tan JC, Felgner PL, Plowe CV, Travassos MA.

mSphere. 2019 Mar 20;4(2). pii: e00097-19. doi: 10.1128/mSphere.00097-19.

36.

How to apply the movement disorder society criteria for diagnosis of progressive supranuclear palsy.

Grimm MJ, Respondek G, Stamelou M, Arzberger T, Ferguson L, Gelpi E, Giese A, Grossman M, Irwin DJ, Pantelyat A, Rajput A, Roeber S, van Swieten JC, Troakes C, Antonini A, Bhatia KP, Colosimo C, van Eimeren T, Kassubek J, Levin J, Meissner WG, Nilsson C, Oertel WH, Piot I, Poewe W, Wenning GK, Boxer A, Golbe LI, Josephs KA, Litvan I, Morris HR, Whitwell JL, Compta Y, Corvol JC, Lang AE, Rowe JB, Höglinger GU; Movement Disorder Society-endorsed PSP Study Group.

Mov Disord. 2019 Aug;34(8):1228-1232. doi: 10.1002/mds.27666. Epub 2019 Mar 18.

37.

Proximity extension assay testing reveals novel diagnostic biomarkers of atypical parkinsonian syndromes.

Jabbari E, Woodside J, Guo T, Magdalinou NK, Chelban V, Athauda D, Lees AJ, Foltynie T, Houlden H, Church A, Hu MT, Rowe JB, Zetterberg H, Morris HR.

J Neurol Neurosurg Psychiatry. 2019 Jul;90(7):768-773. doi: 10.1136/jnnp-2018-320151. Epub 2019 Mar 13.

38.

Cerebral perfusion changes in presymptomatic genetic frontotemporal dementia: a GENFI study.

Mutsaerts HJMM, Mirza SS, Petr J, Thomas DL, Cash DM, Bocchetta M, de Vita E, Metcalfe AWS, Shirzadi Z, Robertson AD, Tartaglia MC, Mitchell SB, Black SE, Freedman M, Tang-Wai D, Keren R, Rogaeva E, van Swieten J, Laforce R, Tagliavini F, Borroni B, Galimberti D, Rowe JB, Graff C, Frisoni GB, Finger E, Sorbi S, de Mendonça A, Rohrer JD, MacIntosh BJ, Masellis M; GENetic Frontotemporal dementia Initiative (GENFI) .

Brain. 2019 Apr 1;142(4):1108-1120. doi: 10.1093/brain/awz039. Erratum in: Brain. 2019 Jun 1;142(6):e28.

39.

In vivo evidence for pre-symptomatic neuroinflammation in a MAPT mutation carrier.

Bevan-Jones WR, Cope TE, Jones PS, Passamonti L, Hong YT, Fryer T, Arnold R, Coles JP, Aigbirhio FI, O'Brien JT, Rowe JB.

Ann Clin Transl Neurol. 2019 Jan 2;6(2):373-378. doi: 10.1002/acn3.683. eCollection 2019 Feb.

40.

Large incidental gastrointestinal stromal tumors in a patient presenting with acutely symptomatic nephrolithiasis: A case report.

Obinero C, Makar GS, Rowe JS, Makar MS, Holdbrook T, Hageboutros A, Spitz FR, Kovacs JE.

Radiol Case Rep. 2019 Feb 26;14(5):555-560. doi: 10.1016/j.radcr.2019.02.005. eCollection 2019 May.

41.

Multi-scale stochastic organization-oriented coarse-graining exemplified on the human mitotic checkpoint.

Henze R, Mu C, Puljiz M, Kamaleson N, Huwald J, Haslegrave J, di Fenizio PS, Parker D, Good C, Rowe JE, Ibrahim B, Dittrich P.

Sci Rep. 2019 Mar 7;9(1):3902. doi: 10.1038/s41598-019-40648-w.

42.

Prognostic importance of apathy in syndromes associated with frontotemporal lobar degeneration.

Lansdall CJ, Coyle-Gilchrist ITS, Vázquez Rodríguez P, Wilcox A, Wehmann E, Robbins TW, Rowe JB.

Neurology. 2019 Apr 2;92(14):e1547-e1557. doi: 10.1212/WNL.0000000000007249. Epub 2019 Mar 6.

43.

Liver and muscle glycogen oxidation and performance with dose variation of glucose-fructose ingestion during prolonged (3 h) exercise.

King AJ, O'Hara JP, Arjomandkhah NC, Rowe J, Morrison DJ, Preston T, King RFGJ.

Eur J Appl Physiol. 2019 May;119(5):1157-1169. doi: 10.1007/s00421-019-04106-9. Epub 2019 Mar 6.

44.

Functional network resilience to pathology in presymptomatic genetic frontotemporal dementia.

Rittman T, Borchert R, Jones S, van Swieten J, Borroni B, Galimberti D, Masellis M, Tartaglia MC, Graff C, Tagliavini F, Frisoni GB, Laforce R Jr, Finger E, Mendonça A, Sorbi S, Rohrer JD, Rowe JB; Genetic Frontotemporal Dementia Initiative (GENFI).

Neurobiol Aging. 2019 May;77:169-177. doi: 10.1016/j.neurobiolaging.2018.12.009. Epub 2019 Jan 4.

45.

The impact of the graft-versus-leukemia effect on survival in acute lymphoblastic leukemia.

Yeshurun M, Weisdorf D, Rowe JM, Tallman MS, Zhang MJ, Wang HL, Saber W, de Lima M, Sandmaier BM, Uy G, Kamble RT, Cairo MS, Cooper BW, Cahn JY, Ganguly S, Camitta B, Verdonck LF, Dandoy C, Diaz MA, Savani BN, George B, Liesveld J, McGuirk J, Byrne M, Grunwald MR, Drobyski WR, Pulsipher MA, Abdel-Azim H, Prestidge T, Wieduwilt MJ, Martino R, Norkin M, Beitinjaneh A, Seo S, Nishihori T, Wirk B, Frangoul H, Bashey A, Mori S, Marks DI, Bachanova V.

Blood Adv. 2019 Feb 26;3(4):670-680. doi: 10.1182/bloodadvances.2018027003.

46.

Disease-informed brain mapping teaches important lessons about the human brain.

Dagher A, Lehéricy S, Rowe JB, Siebner HR.

Neuroimage. 2019 Apr 15;190:1-3. doi: 10.1016/j.neuroimage.2019.02.040. Epub 2019 Feb 21. No abstract available.

PMID:
30798013
47.

The Electronic Health Record: Documenting the Unique Contributions of Social Workers.

Rowe J, Rizzo VM, Guthrie D, Vail MR, Kang SY, Golden R.

Health Soc Work. 2019 May 1;44(2):123-128. doi: 10.1093/hsw/hlz006. No abstract available.

PMID:
30796826
48.

Quality Risk Management Framework: Guidance for Successful Implementation of Risk Management in Clinical Development.

Suprin M, Chow A, Pillwein M, Rowe J, Ryan M, Rygiel-Zbikowska B, Wilson KJ, Tomlin I.

Ther Innov Regul Sci. 2019 Jan;53(1):36-44. doi: 10.1177/2168479018817752.

PMID:
30789098
49.

Calm in the midst of cytokine storm: a collaborative approach to the diagnosis and treatment of hemophagocytic lymphohistiocytosis and macrophage activation syndrome.

Halyabar O, Chang MH, Schoettler ML, Schwartz MA, Baris EH, Benson LA, Biggs CM, Gorman M, Lehmann L, Lo MS, Nigrovic PA, Platt CD, Priebe GP, Rowe J, Sundel RP, Surana NK, Weinacht KG, Mann A, Yuen JC, Meleedy-Rey P, Starmer A, Banerjee T, Dedeoglu F, Degar BA, Hazen MM, Henderson LA.

Pediatr Rheumatol Online J. 2019 Feb 14;17(1):7. doi: 10.1186/s12969-019-0309-6.

50.

Imaging Tau, Neuroinflammation, and Aβ in Dementia With Lewy Bodies: A Deep-Phenotyping Case Report.

Mak E, Surendranathan A, Nicastro N, Aigbirhio F, Rowe J, O'Brien J.

Mov Disord Clin Pract. 2018 Nov 8;6(1):77-80. doi: 10.1002/mdc3.12689. eCollection 2019 Jan. No abstract available.

Supplemental Content

Support Center